JACCRO-GC-07

UMIN000011552 📎

Regimen

Experimental
adjuvant S-1 + docetaxel
Control
adjuvant S-1 alone

Population

Stage III gastric cancer after R0 resection (Asian population)

Key finding

3y RFS 66% vs 50% (HR 0.632, 99.99% CI 0.400-0.998, P<0.001); substantially higher neutropenia in doublet

Source: PMID 30925125

Timeline

    Guideline citations

    • CSCO GASTRIC 2025 (p.63)⚠️ OCR source